Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Rift Valley fever: biology and epidemiology.

Wright D, Kortekaas J, Bowden TA, Warimwe GM.

J Gen Virol. 2019 Aug;100(8):1187-1199. doi: 10.1099/jgv.0.001296. Epub 2019 Jul 16.

PMID:
31310198
2.

Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Tuju J, Mackinnon MJ, Abdi AI, Karanja H, Musyoki JN, Warimwe GM, Gitau EN, Marsh K, Bull PC, Urban BC.

PLoS Pathog. 2019 Jul 1;15(7):e1007870. doi: 10.1371/journal.ppat.1007870. eCollection 2019 Jul. Erratum in: PLoS Pathog. 2019 Aug 15;15(8):e1008018.

3.

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components.

Fedosyuk S, Merritt T, Peralta-Alvarez MP, Morris SJ, Lam A, Laroudie N, Kangokar A, Wright D, Warimwe GM, Angell-Manning P, Ritchie AJ, Gilbert SC, Xenopoulos A, Boumlic A, Douglas AD.

Vaccine. 2019 Apr 29. pii: S0264-410X(19)30532-8. doi: 10.1016/j.vaccine.2019.04.056. [Epub ahead of print]

PMID:
31047679
4.

Complete Genome Sequences of Dengue Virus Type 2 Strains from Kilifi, Kenya.

Kamau E, Agoti CN, Ngoi JM, de Laurent ZR, Gitonga J, Cotten M, Phan MVT, Nokes DJ, Delwart E, Sanders E, Warimwe GM.

Microbiol Resour Announc. 2019 Jan 24;8(4). pii: e01566-18. doi: 10.1128/MRA.01566-18. eCollection 2019 Jan.

5.

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus.

Allen ER, Krumm SA, Raghwani J, Halldorsson S, Elliott A, Graham VA, Koudriakova E, Harlos K, Wright D, Warimwe GM, Brennan B, Huiskonen JT, Dowall SD, Elliott RM, Pybus OG, Burton DR, Hewson R, Doores KJ, Bowden TA.

Cell Rep. 2018 Dec 26;25(13):3750-3758.e4. doi: 10.1016/j.celrep.2018.12.001.

6.

Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya.

Bett B, Lindahl J, Sang R, Wainaina M, Kairu-Wanyoike S, Bukachi S, Njeru I, Karanja J, Ontiri E, Kariuki Njenga M, Wright D, Warimwe GM, Grace D.

Epidemiol Infect. 2018 Dec 5:1-9. doi: 10.1017/S0950268818003242. [Epub ahead of print]

7.

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016.

Clark MHA, Warimwe GM, Di Nardo A, Lyons NA, Gubbins S.

PLoS Negl Trop Dis. 2018 Jul 23;12(7):e0006627. doi: 10.1371/journal.pntd.0006627. eCollection 2018 Jul. Review.

8.

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model.

Munster VJ, Wells D, Lambe T, Wright D, Fischer RJ, Bushmaker T, Saturday G, van Doremalen N, Gilbert SC, de Wit E, Warimwe GM.

NPJ Vaccines. 2017 Oct 16;2:28. doi: 10.1038/s41541-017-0029-1. eCollection 2017.

9.

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.

Gilbert SC, Warimwe GM.

Vaccine. 2017 Aug 16;35(35 Pt A):4461-4464. doi: 10.1016/j.vaccine.2017.04.085. Epub 2017 May 30. Review.

10.

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle.

Dulal P, Wright D, Ashfield R, Hill AV, Charleston B, Warimwe GM.

Vaccine. 2016 Apr 29;34(20):2296-8. doi: 10.1016/j.vaccine.2016.03.061. Epub 2016 Mar 25.

11.

Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria.

Warimwe GM, Abdi AI, Muthui M, Fegan G, Musyoki JN, Marsh K, Bull PC.

Infect Immun. 2016 Apr 22;84(5):1331-1335. doi: 10.1128/IAI.00772-15. Print 2016 May.

12.

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.

Warimwe GM, Gesharisha J, Carr BV, Otieno S, Otingah K, Wright D, Charleston B, Okoth E, Elena LG, Lorenzo G, Ayman el-B, Alharbi NK, Al-dubaib MA, Brun A, Gilbert SC, Nene V, Hill AV.

Sci Rep. 2016 Feb 5;6:20617. doi: 10.1038/srep20617.

13.

Global selection of Plasmodium falciparum virulence antigen expression by host antibodies.

Abdi AI, Warimwe GM, Muthui MK, Kivisi CA, Kiragu EW, Fegan GW, Bull PC.

Sci Rep. 2016 Jan 25;6:19882. doi: 10.1038/srep19882.

14.

Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines.

Morris SJ, Turner AV, Green N, Warimwe GM.

Methods Mol Biol. 2016;1349:121-35. doi: 10.1007/978-1-4939-3008-1_8.

PMID:
26458833
15.

Understanding Rift Valley fever: contributions of animal models to disease characterization and control.

Lorenzo G, López-Gil E, Warimwe GM, Brun A.

Mol Immunol. 2015 Jul;66(1):78-88. doi: 10.1016/j.molimm.2015.02.001. Epub 2015 Feb 26. Review.

PMID:
25725948
16.

An assessment of the impact of host polymorphisms on Plasmodium falciparum var gene expression patterns among Kenyan children.

Warimwe GM, Fegan G, Kiragu EW, Musyoki JN, Macharia AW, Marsh K, Williams TN, Bull PC.

BMC Infect Dis. 2014 Sep 29;14:524. doi: 10.1186/1471-2334-14-524.

17.

Plasmodium falciparum antigenic variation: relationships between widespread endothelial activation, parasite PfEMP1 expression and severe malaria.

Abdi AI, Fegan G, Muthui M, Kiragu E, Musyoki JN, Opiyo M, Marsh K, Warimwe GM, Bull PC.

BMC Infect Dis. 2014 Mar 28;14:170. doi: 10.1186/1471-2334-14-170.

18.

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC.

Virol J. 2013 Dec 5;10:349. doi: 10.1186/1743-422X-10-349.

19.

Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.

Naranbhai V, Hill AV, Abdool Karim SS, Naidoo K, Abdool Karim Q, Warimwe GM, McShane H, Fletcher H.

J Infect Dis. 2014 Feb 15;209(4):500-9. doi: 10.1093/infdis/jit494. Epub 2013 Sep 16.

20.

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.

Warimwe GM, Fletcher HA, Olotu A, Agnandji ST, Hill AV, Marsh K, Bejon P.

BMC Med. 2013 Aug 21;11:184. doi: 10.1186/1741-7015-11-184.

21.

Plasmodium falciparum var gene expression homogeneity as a marker of the host-parasite relationship under different levels of naturally acquired immunity to malaria.

Warimwe GM, Recker M, Kiragu EW, Buckee CO, Wambua J, Musyoki JN, Marsh K, Bull PC.

PLoS One. 2013 Jul 29;8(7):e70467. doi: 10.1371/journal.pone.0070467. Print 2013.

22.

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.

Warimwe GM, Murungi LM, Kamuyu G, Nyangweso GM, Wambua J, Naranbhai V, Fletcher HA, Hill AV, Bejon P, Osier FH, Marsh K.

PLoS One. 2013;8(2):e57320. doi: 10.1371/journal.pone.0057320. Epub 2013 Feb 20.

23.

Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.

Chan JA, Howell KB, Reiling L, Ataide R, Mackintosh CL, Fowkes FJ, Petter M, Chesson JM, Langer C, Warimwe GM, Duffy MF, Rogerson SJ, Bull PC, Cowman AF, Marsh K, Beeson JG.

J Clin Invest. 2012 Sep;122(9):3227-38. doi: 10.1172/JCI62182. Epub 2012 Aug 1.

24.

Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles.

Warimwe GM, Fegan G, Musyoki JN, Newton CR, Opiyo M, Githinji G, Andisi C, Menza F, Kitsao B, Marsh K, Bull PC.

Sci Transl Med. 2012 Apr 11;4(129):129ra45. doi: 10.1126/scitranslmed.3003247.

25.

Plasmodium falciparum var gene expression is modified by host immunity.

Warimwe GM, Keane TM, Fegan G, Musyoki JN, Newton CR, Pain A, Berriman M, Marsh K, Bull PC.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21801-6. doi: 10.1073/pnas.0907590106. Epub 2009 Dec 11.

26.

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.

Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, Osier FH, Bancone G, Avellino P, Blot I, Fegan G, Bull PC, Williams TN, Conway DJ, Marsh K, Modiano D.

PLoS One. 2007 Oct 3;2(10):e978.

Supplemental Content

Loading ...
Support Center